SeQuent Scientific launches Citramox LA injection in 10 European countries
SeQuent said the new approval builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals